fda ruling on tirzepatide accepts generic bids as new pill outperforms Ozempic FDA Approves Tirzepatide, A Potential

Retaglutide clinical trial results The benefits of the triple agonist also extended to the treatment of nonalcoholic fatty liver disease

Endocrinology 150, 26542659

You prefer daily pills over weekly injections

Concerning astrocytes and the brain, the available information on the expression and the physiological functions of GSTs and alterations in GST expression and functions in the brain under physiological and pathological conditions has previously been summarized (Dringen et al

Most patients need testing every 3-6 months during active treatment, with baseline testing before starting medications (American Diabetes Association 2025)